Blue Eagle Immo
0459.676.862 · rovalta.com · 22/09/2026
Blue Eagle Immo
Overview
What does Blue Eagle Immo do?
Blue Eagle Immo is a Public limited company incorporated in 1996. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Beerse.
2340 Beerse · FlandreSee on map
Joint committees (2)
- 100
- 218
Trend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Revenue | 38,7 k € | -43.0% | 67,8 k € | +13.9% | 59,5 k € | -81.1% | 315,1 k € | – | – | – | 1 € | -100.0% | 2,6 M € | +620% | 366,7 k € | -17.9% | 446,6 k € | -49.6% | 886,1 k € | -10.0% | 985,1 k € | +4.0% | 947 k € | +17.3% | 807,3 k € | -42.7% | 1,4 M € | -88.0% | 11,8 M € | -32.6% | 17,4 M € | -15.6% | 20,7 M € | ||||
| EBITDA | 121,1 k € | +31.0% | 92,4 k € | -26.1% | 125,1 k € | -42.9% | 219,1 k € | -13.0% | 251,7 k € | +17.8% | 213,7 k € | -10.5% | 238,8 k € | +12.1% | 213,1 k € | -92.4% | 2,8 M € | +565% | 419,9 k € | +1.4% | 414,1 k € | +22.3% | 338,7 k € | +869% | 35 k € | +105% | -682,5 k € | -136% | 1,9 M € | +308% | -918,6 k € | -193% | 988,1 k € | -81.9% | 5,5 M € | +320% | 1,3 M € |
| Operating result | 44,1 k € | +260% | -27,5 k € | -636% | 5,1 k € | -94.8% | 98,9 k € | -25.3% | 132,4 k € | +38.1% | 95,8 k € | -9.0% | 105,4 k € | +23.8% | 85,1 k € | -96.8% | 2,7 M € | +893% | 267 k € | +83.6% | 145,5 k € | +145% | -319,9 k € | -179% | -114,9 k € | +86.1% | -825,9 k € | -147% | 1,8 M € | +258% | -1,1 M € | -239% | 802,1 k € | -84.9% | 5,3 M € | +383% | 1,1 M € |
| Net result | 34,2 k € | +226% | -27,1 k € | -3689% | 755,7 € | -99.0% | 74,7 k € | -36.6% | 117,7 k € | +49.2% | 78,9 k € | -10.4% | 88,1 k € | +27.3% | 69,2 k € | -96.9% | 2,3 M € | +235% | 671,1 k € | +198% | -686,3 k € | -123% | -307,5 k € | -8.0% | -284,6 k € | +57.7% | -672,4 k € | -148% | 1,4 M € | +174% | -1,9 M € | -337% | 799,4 k € | -75.7% | 3,3 M € | +645% | 441,9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 376,4 k € | +10.0% | 342,2 k € | -7.3% | 369,3 k € | +0.2% | 368,6 k € | +25.4% | 293,9 k € | -43.3% | 518,2 k € | +18.0% | 439,2 k € | +25.1% | 351,1 k € | -94.4% | 6,3 M € | +55.8% | 4 M € | +20.0% | 3,4 M € | -17.0% | 4 M € | -7.1% | 4,4 M € | -6.1% | 4,6 M € | -12.7% | 5,3 M € | +12.5% | 4,7 M € | -28.6% | 6,6 M € | +13.7% | 5,8 M € | +131% | 2,5 M € |
| Total assets | 870,2 k € | -14.3% | 1 M € | +93.5% | 524,5 k € | -10.9% | 588,4 k € | -32.5% | 872,2 k € | -29.6% | 1,2 M € | -3.7% | 1,3 M € | -81.5% | 7 M € | -2.0% | 7,1 M € | +38.4% | 5,1 M € | +14.1% | 4,5 M € | -9.3% | 5 M € | -3.6% | 5,1 M € | -3.4% | 5,3 M € | -13.6% | 6,2 M € | -36.9% | 9,8 M € | -26.8% | 13,3 M € | +18.2% | 11,3 M € | +32.5% | 8,5 M € |
| Cash | 142,9 k € | +195% | 48,5 k € | -84.2% | 306,5 k € | -3.0% | 316,1 k € | -35.2% | 487,6 k € | +51.3% | 322,3 k € | +27.4% | 253 k € | -95.9% | 6,2 M € | +61.2% | 3,8 M € | -5.0% | 4 M € | +34.4% | 3 M € | -15.0% | 3,5 M € | +6.7% | 3,3 M € | -20.0% | 4,1 M € | -10.9% | 4,6 M € | -12.7% | 5,3 M € | +34.3% | 3,9 M € | +53.6% | 2,6 M € | +597% | 368,7 k € |
| Debts | 493,8 k € | -26.6% | 673 k € | +334% | 155,2 k € | -29.4% | 219,9 k € | -61.3% | 568,1 k € | -20.3% | 712,7 k € | -16.0% | 848,4 k € | -87.2% | 6,6 M € | +707% | 819,1 k € | -25.2% | 1,1 M € | +23.3% | 888,5 k € | +48.4% | 598,8 k € | -24.3% | 791,4 k € | +16.9% | 676,9 k € | -4.0% | 704,8 k € | -70.7% | 2,4 M € | -39.5% | 4 M € | +48.1% | 2,7 M € | -18.5% | 3,3 M € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | – | – | – | – | – | – | – | – | – | – | – | – | 1,0 ETP | -9.1% | 1,1 ETP | +120% | 0,5 ETP | 0.0% | 0,5 ETP | -88.9% | 4,5 ETP | -40.0% | 7,5 ETP | -35.9% | 11,7 ETP | ||||||||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 17 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Blue Eagle Consult● Active | 0468.243.447 |
Blue Eagle Invest● Active | 0476.067.387 |
DAFRA IMMO● Active | 0441.342.872 |
Dynamo Beirs● Active | 1005.876.340 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/07/2026 | 04/07/2025 | 05/07/2024 | 30/06/2023 | 15/06/2022 | 29/06/2021 |
| General meeting | 05/06/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 05/06/2026 | 03/07/2026 | Dutch | |
| Full model | 31/12/2024 | 06/06/2025 | 04/07/2025 | Dutch | |
| Full model | 31/12/2023 | 07/06/2024 | 05/07/2024 | Dutch | |
| Full model | 31/12/2022 | 02/06/2023 | 30/06/2023 | Dutch | |
| Full model | 31/12/2021 | 03/06/2022 | 15/06/2022 | Dutch | |
| Full model | 31/12/2020 | 04/06/2021 | 29/06/2021 | Dutch | |
| Full model | 31/12/2019 | 05/06/2020 | 12/06/2020 | Dutch | |
| Full model | 31/12/2018 | 07/06/2019 | 11/06/2019 | Dutch | |
| Full model | 31/12/2017 | 01/06/2018 | 26/06/2018 | Dutch | |
| Full model | 31/12/2016 | 29/05/2017 | 28/06/2017 | Dutch | |
| Full model | 31/12/2015 | 03/06/2016 | 23/08/2016 | Dutch | |
| Full model | 31/12/2014 | 05/06/2015 | 29/06/2015 | Dutch | |
| Full model | 31/12/2013 | 06/06/2014 | 15/07/2014 | Dutch | |
| Full model | 31/12/2012 | 10/06/2013 | 23/07/2013 | Dutch | |
| Full model | 31/12/2011 | 01/06/2012 | 16/11/2012 | Dutch | |
| Full model | 31/12/2010 | 03/06/2011 | 22/06/2011 | Dutch | |
| Full model | 31/12/2009 | 30/06/2010 | 25/08/2010 | Dutch | |
| Full model | 31/12/2008 | 05/06/2009 | 22/06/2009 | Dutch | |
| Full model | 31/12/2007 | 31/07/2008 | 28/08/2008 | Dutch | |
| Full model | 31/12/2006 | 01/06/2007 | 25/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 17 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates07/08/2024ONTSLAGEN - BENOEMINGEN
- Registered office09/03/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - MAATSCHAPPELIJKE ZETEL
- Mandates20/08/2018ONTSLAGEN - BENOEMINGEN
- Mandates17/06/2014ONTSLAGEN - BENOEMINGEN
- Mandates22/05/2013ONTSLAGEN - BENOEMINGEN
- Mandates25/03/2009ONTSLAGEN - BENOEMINGEN
- Mandates22/09/2008ONTSLAGEN - BENOEMINGEN
- Mandates15/12/2006BOEKJAAR - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202534,2 k €↑
- 2024Annual accounts 2024-27,1 k €↓
- 2023Annual accounts 2023755,7 €↓
- 2022Annual accounts 202274,7 k €↓
- 2022Name changeBlue Eagle Immo
- 2021Annual accounts 2021117,7 k €↑
- 2020Annual accounts 202078,9 k €↓
- 2019Annual accounts 201988,1 k €↑
- 2018Annual accounts 201869,2 k €↓
- 2017Annual accounts 20172,3 M €↑
- 2016Annual accounts 2016671,1 k €↑
- 2015Annual accounts 2015-686,3 k €↓
- 2014Annual accounts 2014-307,5 k €↓
- 2013Annual accounts 2013-284,6 k €↑
- 2012Annual accounts 2012-672,4 k €↓
- 2011Annual accounts 20111,4 M €↑
- 2009Annual accounts 2009-1,9 M €↓
- 2008Annual accounts 2008799,4 k €↓
- 2007Annual accounts 20073,3 M €↑
- 2006Annual accounts 2006441,9 k €
- 2006Name changeDAFRA PHARMA
- 30/12/1996IncorporationPublic limited company